Ariel Investments - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 86 filers reported holding ENZO BIOCHEM INC in Q2 2020. The put-call ratio across all filers is 2.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ariel Investments ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q1 2021$819,000
-62.7%
237,992
-72.7%
0.01%
-68.0%
Q4 2020$2,195,000
+25.1%
871,112
+4.8%
0.02%0.0%
Q3 2020$1,754,000
+18.8%
831,092
+26.1%
0.02%
+13.6%
Q2 2020$1,477,000
-32.9%
659,316
-24.2%
0.02%
-43.6%
Q1 2020$2,201,000
-13.3%
870,079
-9.9%
0.04%
+21.9%
Q4 2019$2,539,000
-31.3%
965,584
-5.9%
0.03%
-34.7%
Q3 2019$3,695,000
+238.7%
1,026,313
+217.1%
0.05%
+250.0%
Q2 2019$1,091,000323,6150.01%
Other shareholders
ENZO BIOCHEM INC shareholders Q2 2020
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,436,771$7,822,00010.43%
VIEX Capital Advisors, LLC 1,736,087$5,573,0008.96%
HARBERT FUND ADVISORS, INC. 5,175,913$16,615,0004.19%
AMH Equity Ltd 596,742$1,916,0002.66%
Potomac Capital Management, Inc. 208,000$668,0000.59%
Agate Pass Investment Management, LLC 24,292$78,0000.05%
RBF Capital, LLC 250,359$804,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$82,0000.05%
Corsair Capital Management 58,657$188,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 319,500$1,026,0000.02%
View complete list of ENZO BIOCHEM INC shareholders